BCRX · Transaction Nov 13, 2025 · Filed Dec 15, 2025 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · BCRX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
BioCryst Pharmaceuticals Inc
Biotechnology
$9.94
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET · BCRX
MethodologyBCRX
BioCryst Pharmaceuticals Inc
Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
72/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BCRX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BioCryst Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Listed since
1994
Employees
435
Country
US
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$9.94
Last session
Day high
$9.94
Last session
Day low
$9.94
Last session
Previous close
$9.94
52W high
$11.11
-10.53% from high
52W low
$6.24
76% of range
Market cap
$2.5B
P/E
9.56×
EPS
$-2.6000
Beta
0.43
Shares out
255.5M
Avg volume
3.8M
VWAP
$9.94
Last session
Price history computed in-house
1W
-3.87%
1M
+7.00%
3M
+13.73%
1Y
+18.62%
YTD
+27.44%
SMA 50 $9.49 · above
SMA 200 $8.38 · above
52W position 76%
BCRX overview
Related filings and maps
Public disclosures
Congress activity in BCRX
Official filing ↗
BioCryst Pharmaceuticals, Inc. · Transaction Oct 16, 2023 · Filed Nov 11, 2023 · $1,001 to $15,000
BioCryst Pharmaceuticals, Inc. · Transaction Sep 15, 2023 · Filed Oct 15, 2023 · $1,001 to $15,000
BioCryst Pharmaceuticals, Inc. · Transaction Aug 11, 2022 · Filed Sep 16, 2022 · $1,001 to $15,000
Federal contracts
BCRX contract awards, year to date.
Public federal awards linked to this ticker.
$181.8K
Refresh interval: 12hSource: Federal contract awards
Department of Veterans Affairs
$151.5K
ORLADEYO 150MG CAP
ORLADEYO 150MG CAP
May 19, 2026
Department of Veterans Affairs
$30.3K
EMERGENCY ORLADEYO
EMERGENCY ORLADEYO
May 21, 2026
Lobbying spend
BCRX lobbying filings, year to date.
Registered lobbying filings matched to BioCryst Pharmaceuticals Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BCRX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BCRX.
Options
Sovereign unlock shows live options positioning for BCRX.